HIF-1α-deficient tumor-infiltrating CD8+ lymphocytes were characterized by a drop in expression of the costimulatory molecules CD137 and GITR, and in the checkpoint receptors PD-1, LAG3, and TIM3 (Figure 3E). Here, TNFRSF18 is linked to neoplasm.